4UW-10837-09336
3 vaccinations
2 coded responses
23 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 834 / ID
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Pfizer-BioNTech
- 2021-03-11
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-17
- 2021-03-18
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
-
2021-05-06
Survey response — day 35, dose 2MedDRA: Pruritus, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Developed a head to toe rash. Doctors assume its from taking cephalexin however rash didnt develop until 2 days after my last dose of antibiotic. Got a kenalog injection on n Monday and rash is fading but still visible. Itching persistsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-13
- 2021-07-03
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2022-04-03
- 2022-05-05
-
2022-06-02
Survey response — 6 months, dose 3MedDRA: Pre-existing disease — Feeling: GoodFree text: I am in the process of working with university of (b)(6) Rhuematologists to figure out my autoimmune condition. I have hashimotos hypothyroidism and was diagnosed with SEL 9 years ago. Current results indicate it's probably not lupus.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — day 35, dose 2
Symptoms: Developed a head to toe rash. Doctors assume its from taking cephalexin however rash didnt develop until 2 days after my last dose of antibiotic. Got a kenalog injection on n Monday and rash is fading but still visible. Itching persists
Release 11 — 6 months, dose 3
Symptoms: I am in the process of working with university of (b)(6) Rhuematologists to figure out my autoimmune condition. I have hashimotos hypothyroidism and was diagnosed with SEL 9 years ago. Current results indicate it's probably not lupus.
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release